100% Rule

No management charges are levied on the investor at the point of investment for advised subscriptions received by a financial adviser, resulting in up to 100% allocation of subscription. This ensures up to 100% tax efficiency for investors. Deepbridge Capital fees are paid by Investee Companies and are disclosed in the Information Memorandum.

Read More

About Deepbridge capital

Deepbridge Capital aims to redefine the growth capital market by providing investors with access to opportunities which are sourced, reviewed and managed by our team of sector specialists. 

Supporting energetic, passionate and knowledgeable management teams, Deepbridge seeks to identify highly innovative companies to grow into highly successful companies, with a view to providing optimal returns to our investors.

As investment specialists in the technology, life sciences and renewable energy sectors, we work with investee companies throughout their funding journey with an eye always on producing a suitable exit for our investors.

Read More

Latest News

Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.

Our People

Introducing the team that keep Deepbridge running

Our Investments

See what our investee companies say about our support and commitment to them

When looking for our first external funding, it was important to our team that we worked with an organisation that not only could provide us with the capital we needed but which would also proactively work with us to drive the business forward – we have been delighted with Deepbridge’s commitment to both aspects.  Ultimately it was also important to work with individuals who we actually liked!

 Martyn Noble, Hurricane Modular Commerce (Chairman & CEO)

Having raised funds, and provided funds, for entrepreneurial businesses in the past, I appreciate the value add that a supportive and passionate VC can bring to a young business.  Working with Deepbridge was therefore a natural fit when considering our funding options at Chainvine.

 Oliver Oram, Chainvine (CEO)

It is important for us to work in partnership with supporters who share our passion for what we do, and therefore Deepbridge are a fantastic partner for Sky Medical Technology. Their understanding of the commercialisation process of a tech company such as ours has been a real asset. Bernard Ross, Sky Medical Technology Limited (CEO)

"It was extremely important for Elasmogen that we worked with the right funding partners. Deepbridge’s life Sciences team understands our company and our sector, with their support therefore being invaluable and much appreciated.”

Caroline Barelle, Elasmogen Limited (CEO)
Having consistently demonstrated their faith in our proposition and our objectives, we have been delighted to work with the Deepbridge team as Arbnco has grown. Their commercial experience and their genuine commitment to working in partnership with us has been invaluable. Maureen Eisbrenner, arbnco (CEO)
View more